AI assistant
Sending…
Chemours Co — Director's Dealing 2022
Jul 5, 2022
31561_dirs_2022-07-05_d3f6b861-08a0-4987-b4e6-886f32c657a9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2022-06-30
Reporting Person: Kane Erin N (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-06-30 | Stock Units | $ | A | 780.762 | Acquired | Common Stock (780.762) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 32008.6578 | Direct |
Footnotes
F1: Includes stock units and dividend equivalent units.
F2: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.
F3: Payable upon separation from service.
More from Chemours Co
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3